Investors & Media

What's new.

Press releases

Press releases.

Immutep Receives A$3.4 million R&D French Tax Incentive

September 29th 2021
press releases

Immutep to Present at Healthcare Investor Conferences

September 28th 2021
press releases

Immutep Completes Recruitment of 2nd line PD-1/PD-L1 refractory NSCLC Patients in TACTI-002

September 1st 2021
press releases

Investor updates

Investor updates.

Investor Update - April 2021

April 14th 2021
investor updates

Investor Update - August 2020

August 17th 2020
investor updates

Investor Update - November 2019

November 22nd 2019
investor updates

Analyst reports

Analyst reports.

Maxim Group - The Case for LAG-3 is Building

September 20th 2021
analyst reports

Maxim Group - Annual FY Update; AIPAC Final Data Approaching

August 30th 2021
analyst reports

Maxim Group - Unlocking the Synergistic Benefits of Efti (LAG-3), the Next Checkpoint - Transferring Coverage with a Buy Rating and $8 TP

July 16th 2021
analyst reports